Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[NF kappa B decoy for clinical applications].

Jun-ichi Suzuki1, Mitsuaki Isobe

  • 1Cardiovascular Medicine, Tokyo Medical and Dental University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 28, 2003
PubMed
Summary

Antisense oligodeoxynucleotides (ODNs) and decoy DNA are advancing gene therapy. This review covers decoy DNA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spin-contrast-variation small-angle neutron scattering study of fully and partially swollen silica-filled rubber.

Journal of applied crystallography·2026
Same author

Unified Interpretations of Two Kinds of Needle-Shaped Precipitates Using Transmission Electron Microscopy and Small-Angle Neutron Scattering in Aged Al-Mg<sub>2</sub>Si(-Cu) Alloys.

Nanomaterials (Basel, Switzerland)·2024
Same author

Intermittent hypoxia inhibits mandibular cartilage growth with reduced TGF-β and SOX9 expressions in neonatal rats.

Scientific reports·2021
Same author

A new method for measuring coronary artery diameters with CT spatial profile curves.

Radiography (London, England : 1995)·2021
Same author

Intermittent hypoxia induces turbinate mucosal hypertrophy via upregulating the gene expression related to inflammation and EMT in rats.

Sleep & breathing = Schlaf & Atmung·2020
Same author

Intermittent hypoxia retards mandibular growth and alters RANKL expression in adolescent and juvenile rats.

European journal of orthodontics·2020

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • DNA Technology

Context:

  • Antisense oligodeoxynucleotides (ODNs) regulate disease-related gene transcription.
  • Decoy DNA, a double-stranded DNA transfectant, shows promise for gene therapy.
  • Decoy strategy aids endogenous gene regulation studies and clinical applications.

Purpose:

  • To review the therapeutic potential of decoy DNA technology.
  • To summarize experimental findings in disease models.
  • To outline ongoing clinical trials utilizing decoy DNA.

Summary:

  • Decoy DNA, a novel gene therapy approach, involves transfecting cis-element double-stranded DNA.
  • This strategy has demonstrated efficacy in various disease models.
  • Clinical trials for conditions like coronary angioplasty, arthritis, and dermatitis are underway in Japan.

Impact:

  • Decoy DNA represents a significant advancement in targeted gene regulation.
  • The technology offers a promising new avenue for treating genetic disorders.
  • Successful clinical trials could lead to innovative therapeutic interventions.

Related Experiment Videos